Literature DB >> 9700620

Segmental intestinal ischemia: an improved method of producing small bowel injury.

S B Pillai1, M H Luquette, P T Nowicki, G E Besner.   

Abstract

Previous animal models of intestinal ischemia-reperfusion have been successful in causing considerable mucosal damage, cellular destruction and sepsis. However, this often results in the death of the animal, making it impossible to examine the effects of modulators of the ischemic event. The sequence of morphologic and physiologic changes in the bowel from such injuries continues to be an area of intense examination. We have studied these changes by producing segmental intestinal ischemia in vivo in a rat model. By occluding a first-order branch of the superior mesenteric artery (SMA) and by selectively ligating terminal collateral branches, reproducible segmental intestinal ischemia was achieved. Bowel damage ranged from alterations in the villus structure to frank hemorrhagic necrosis of the intestinal wall. This model allows the study of hypoperfusion injury to the small intestine without total SMA occlusion, thus reducing the overall mortality.

Entities:  

Mesh:

Year:  1998        PMID: 9700620     DOI: 10.3109/08941939809032191

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  3 in total

1.  Structural and neuronal changes in rat ileum after ischemia with reperfusion.

Authors:  Lille-Mor Lindeström; Eva Ekblad
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

2.  Attenuation of graft ischemia-reperfusion injury by urinary trypsin inhibitor in mouse intestinal transplantation.

Authors:  Ji-Ren Yu; Sheng Yan; Xiao-Sun Liu; Yi-Jun Wu; Pei-Feng Fu; Li-Hua Wu; Shu-Sen Zheng
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

3.  Heparin-binding EGF-like growth factor (HB-EGF) therapy for intestinal injury: Application and future prospects.

Authors:  Jixin Yang; Yanwei Su; Yu Zhou; Gail E Besner
Journal:  Pathophysiology       Date:  2013-12-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.